Secondary Logo

Journal Logo

February 1994 - Volume 15 - Issue 2
pp: 81-154

PDF Only


Characterization of Tumor-Infiltrating Lymphocyte Subsets from Human Renal Cell Carcinoma: Specific Reactivity Defined by Cytotoxicity, Interferon-γ Secretion, and Proliferation

Finke, James H.; Rayman, Patricia; Hart, Laura; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 15(2):91-104, February 1994.

Production of Interleukin-2 by EL4 Tumor Cells Induces Natural Killer Cell- and T-Cell-Mediated Immunity

Visseren, Marjan J. W.; Koot, Maarten; van der Voort, Ellen I. H.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 15(2):119-128, February 1994.


PDF Only


Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group Trial

Vlock, Daniel R.; Snyderman, Carl H.; Johnson, Jonas T.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 15(2):134-139, February 1994.

A Comparative Study of Intravenous Versus Intralymphatic Interleukin-2, with Assessment of Effects of Interleukin-2 on Both Peripheral Blood and Thoracic-Duct Lymph

Sarna, Gregory; Machleder, Herbert; Collins, James; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 15(2):140-146, February 1994.

Phase II Studies of Recombinant Human Interleukin-4 in Advanced Renal Cancer and Malignant Melanoma

Margolin, Kim; Aronson, Frederick R.; Sznol, Mario; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 15(2):147-153, February 1994.


PDF Only